| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/23/2004 | CA2812817A1 Purification process |
| 09/23/2004 | CA2759072A1 Allergen peptide fragments and use thereof |
| 09/23/2004 | CA2557737A1 Insulin-like growth factor (igf-i) plasmid-mediated supplementation for therapeutic applications |
| 09/23/2004 | CA2523776A1 Baff mutants with at least one amino acid substitution and methods of their production |
| 09/23/2004 | CA2519083A1 Allergen peptide fragments and use thereof |
| 09/23/2004 | CA2518957A1 Genetic polymorphisms associated with myocardial infarction, methods of detection and uses thereof |
| 09/23/2004 | CA2518944A1 Inhibitors of extracellular hsp90 |
| 09/23/2004 | CA2518912A1 Polypeptide compounds for inhibiting angiogenesis and tumor growth |
| 09/23/2004 | CA2518905A1 Extraction and use of collagen extracted from either a sea mammal or a bony fish |
| 09/23/2004 | CA2518898A1 Nucleic acid compounds for inhibiting angiogenesis and tumor growth |
| 09/23/2004 | CA2518876A1 Phospholipid scramblase 3 |
| 09/23/2004 | CA2518811A1 Plant cells and plant bodies with modified cell growth, development and differentiation |
| 09/23/2004 | CA2518762A1 Purification of peptides from colostrum |
| 09/23/2004 | CA2518669A1 Purification process |
| 09/23/2004 | CA2518552A1 Novel compositions and methods for the treatment of immune related disease |
| 09/23/2004 | CA2518549A1 Soluble hybrid prion proteins and their use in the diagnosis, prevention and treatment of transmissible spongiform encephalopathies |
| 09/23/2004 | CA2518475A1 Irna agents comprising asymmetrical modifications |
| 09/23/2004 | CA2518417A1 Method for increasing resistance against stress factors in plants |
| 09/23/2004 | CA2518406A1 Thiol-mediated drug attachment to targeting peptides |
| 09/23/2004 | CA2518383A1 Il-2 transmembrane constructs |
| 09/23/2004 | CA2518262A1 Uses of il-23 agonists and antagonists; related reagents |
| 09/23/2004 | CA2518058A1 Diagnostic and prognostic compounds and method |
| 09/23/2004 | CA2516919A1 Influenza virus vaccine |
| 09/23/2004 | CA2516023A1 Screening assays for targets and drugs useful in treatment and prevention of lipid metabolism disorders |
| 09/23/2004 | CA2514981A1 Use of recombinant albumin in dialysis after liver failure |
| 09/23/2004 | CA2500521A1 Novel nucleic acids and polypeptides |
| 09/22/2004 | EP1460134A1 SUGAR TRANSFERASE GnT-V HAVING ANGIOGENIC EFFECT |
| 09/22/2004 | EP1460133A1 Nucleic acids with the aid of which plants having an altered metabolite content can be produced |
| 09/22/2004 | EP1460132A1 Antibodies with specific immunoreactivity to thyroid carcinoma cells |
| 09/22/2004 | EP1460131A2 Production of recombinant blood clotting factors in human cell lines |
| 09/22/2004 | EP1460087A1 Methods of treating vascular disease with TNF antagonists |
| 09/22/2004 | EP1460085A1 Genes and proteins for the biosynthesis of the glycopeptide antibiotic teicoplanin |
| 09/22/2004 | EP1460084A1 Novel peptide sy |
| 09/22/2004 | EP1459756A1 REMOVAL PROMOTERS AND INHIBITOR FOR APOPTOSIS CELLS i IN VIVO /i |
| 09/22/2004 | EP1459755A1 Body weight gain inhibitor |
| 09/22/2004 | EP1459754A1 Preventives/remedies for cancer |
| 09/22/2004 | EP1459727A1 Nonhuman model animal unresponsive to immunopotentiating synthetic compound |
| 09/22/2004 | EP1459063A2 Screening method for compounds that modulate neuronal activity |
| 09/22/2004 | EP1458871A2 Soluble recombinant protein production |
| 09/22/2004 | EP1458868A2 Genes and proteins involved in the biosynthesis of lipopeptides |
| 09/22/2004 | EP1458867A2 Gene promoters |
| 09/22/2004 | EP1458866A2 Modified tridegins, production and use thereof as transglutaminase inhibitors |
| 09/22/2004 | EP1458865A2 Human vanilloid receptor protein and polynucleotide sequence encoding same |
| 09/22/2004 | EP1458863A1 A system for stable expression of sirnas in mammalian cells |
| 09/22/2004 | EP1458861A2 Ides, an igg-degrading enzyme of streptococcus pyogenes |
| 09/22/2004 | EP1458857A1 Hxhv virus, nucleic material, peptide material and uses |
| 09/22/2004 | EP1458855A2 Method for the generation of proliferating and differentiating cell lines |
| 09/22/2004 | EP1458852A1 Compositions for the in vitro derivation and culture of embryonic stem (es) cell lines with germline transmission capability and for the culture of adult stem cells |
| 09/22/2004 | EP1458848A2 Nucleic acid nematicides |
| 09/22/2004 | EP1458847A1 Novel nucleic acids, polypeptides, methods of making, and uses thereof |
| 09/22/2004 | EP1458760A1 Entrapped binding proteins as biosensors |
| 09/22/2004 | EP1458758A2 Adiponectin fragments and conjugates |
| 09/22/2004 | EP1458757A1 Process for the purification and/or isolation of biologically active granulocyte colony stimulating factor |
| 09/22/2004 | EP1458756A1 Chemokine mutants acting as chemokine antagonists |
| 09/22/2004 | EP1458755A2 Novel g-protein coupled receptors and dna sequences thereof |
| 09/22/2004 | EP1458754A2 Novel death associated proteins of the thap family and related par4 pathways involved in apoptosis control |
| 09/22/2004 | EP1458753A1 Modified bacterial surface layer proteins |
| 09/22/2004 | EP1458752A2 Polypeptides of pseudomonas aeruginosa |
| 09/22/2004 | EP1458751A2 Antigens for actinobacillus pleuropneumoniae and methods thereof |
| 09/22/2004 | EP1458750A2 Mutated hiv tat |
| 09/22/2004 | EP1458749A2 Bone polypeptide-1 |
| 09/22/2004 | EP1458748A2 Apoptotically active peptides |
| 09/22/2004 | EP1458677A1 3-phenyl-2-arylalkylthiopropionic acid derivatives as selective agonists of ppar-alpha |
| 09/22/2004 | EP1458407A1 Liquid composition of modified factor vii polypeptides |
| 09/22/2004 | EP1458403A2 Compositions and methods for the treatment and clinical remission of psoriasis |
| 09/22/2004 | EP1458247A2 Malleable protein matrix and uses thereof |
| 09/22/2004 | EP1458241A2 Modified antigen-presenting cells |
| 09/22/2004 | EP1458240A2 Nucleic acid constructs useful for glucose regulated production of human insulin in somatic cell lines |
| 09/22/2004 | EP1458234A1 Disruption of the prostaglandin e synthase 2 gene |
| 09/22/2004 | EP1414297A4 Sodium dodecyl sulfate compositions for inactivating prions |
| 09/22/2004 | EP1350104A4 Presenilin enhancers |
| 09/22/2004 | EP1337546A4 Method for detecting hematopoietic stem cells |
| 09/22/2004 | EP1320624B1 Silicatein-mediated synthesis of amorphous silicates and siloxanes and use thereof |
| 09/22/2004 | EP1301238B1 Needles coated with vaccine |
| 09/22/2004 | EP1280819A4 Methods for the purification and aqueous fiber spinning of spider silks and other structural proteins |
| 09/22/2004 | EP1165825A4 Toxicant-induced differential gene expression |
| 09/22/2004 | EP1147122A4 Methods for altering organ mass, controlling fertility and enhancing asexual reproduction in plants |
| 09/22/2004 | EP1090142A4 Methods for determining breast cancer and melanoma by assaying for a plurality of antigens associated therewith |
| 09/22/2004 | EP1087990B1 Method and apparatus for the production of purified plasma proteins |
| 09/22/2004 | EP1019520A4 SCREENING METHODS TO DETECT mRNA TARGETS OF EDITING ENZYMES |
| 09/22/2004 | EP1007803B1 Fire resisting wall |
| 09/22/2004 | EP1007553A4 Zonula occludens toxin receptors |
| 09/22/2004 | EP1003871B1 Trichoderma reesei swollenin protein and encoding dna sequence |
| 09/22/2004 | EP0973806B1 Site protected protein modification |
| 09/22/2004 | EP0938500B1 INTERLEUKIN-1beta-CONVERTING ENZYME (ICE) INHIBITING PEPTIDES |
| 09/22/2004 | EP0917566B1 Recombinant blood-coagulation proteases |
| 09/22/2004 | EP0915970B1 Type c lectins |
| 09/22/2004 | EP0914442B1 Avian polynucleotide vaccine formula |
| 09/22/2004 | EP0904371B1 Use of the green fluorescent protein as a screenable marker for plant transformation |
| 09/22/2004 | EP0854925B1 THE NucA PROTEIN OF HAEMOPHILUS INFLUENZAE AND THE GENE ENCODING THAT PROTEIN |
| 09/22/2004 | EP0742822B1 Folding proteins |
| 09/22/2004 | EP0737207B1 Inhibitors of human plasmin derived from the kunitz domains |
| 09/22/2004 | EP0726914B1 Cell surface protein expressed on human cortical thymocyte and their use |
| 09/22/2004 | EP0706575B1 Retroviral vectors for transducing beta-globin gene and beta-locus control region derivatives |
| 09/22/2004 | EP0706571B1 Tuberculosis vaccine |
| 09/22/2004 | EP0682708B1 Antiviral composition of viral protein trans-dominant variants |
| 09/22/2004 | EP0636179B1 Oil-body proteins as carriers of high-value peptides in plants |
| 09/22/2004 | EP0587805B2 Bovine herpesvirus type 1 deletion mutants, vaccines based thereon, diagnostic kits for detection of bovine herpesvirus type 1 |
| 09/22/2004 | CN1531653A Method for identification of proteins from intracellular bacteria |
| 09/22/2004 | CN1531600A New polynucleotides and polypeptides of IFN 2-21 gene |